Live Nasdaq Composite: Market Sentiment Improves as Oil Prices Ease, Mideast Talk Hopes Rise

Investing

Eli Lilly : LLY

All Eli Lilly Articles

668 Articles

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 3, 2019 at 12:10 PM EDT

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th…

Lee Jackson | Sep 27, 2019 at 10:45 AM EDT

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 9, 2019 at 12:00 PM EDT

Surprising Reaction to Lung Cancer Study Results

Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of…

Jon C. Ogg | Sep 5, 2019 at 2:00 PM EDT

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

NextCure appears to be one of those companies that has flown under the radar of the investing community since its…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 13, 2019 at 11:00 AM EDT

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

1 … 17 18 19 20 21 … 45

Eli Lilly : LLY

All Eli Lilly Articles

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

Surprising Reaction to Lung Cancer Study Results

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Big Pharma Sees a Rising Tide in Short Interest

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Live Nasdaq Composite: Market Sentiment Improves as Oil Prices Ease, Mideast Talk Hopes Rise

SaaS Business Leader Warns “The Old Moat Is Gone” After Rebuilding 20 Years of Software in 3 Days. Here’s What Still Protects Software Companies From AI

Why Retiring Without a Plan for Your Time Is More Dangerous Than Retiring Without Enough Money

Options Traders Bet $550M Against Tesla Ahead of Earnings

She's a 62-Year-Old Widow Banking on the COLA Raise. The Survivor-Benefit Timing She's Ignoring Is Worth Far More.

"Wait, Did I Just Hear That Right?": Suze Orman Catches a Caller's Advisor Overcharging Her by $23,000 a Year

SaaS Business Leader Warns “The Old Moat Is Gone” After Rebuilding 20 Years of Software in 3 Days. Here’s What Still Protects Software Companies From AI

Why Retiring Without a Plan for Your Time Is More Dangerous Than Retiring Without Enough Money

Eli Lilly : LLY

All Eli Lilly Articles

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

Surprising Reaction to Lung Cancer Study Results

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Big Pharma Sees a Rising Tide in Short Interest

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Live Nasdaq Composite: Market Sentiment Improves as Oil Prices Ease, Mideast Talk Hopes Rise

SaaS Business Leader Warns “The Old Moat Is Gone” After Rebuilding 20 Years of Software in 3 Days. Here’s What Still Protects Software Companies From AI

Why Retiring Without a Plan for Your Time Is More Dangerous Than Retiring Without Enough Money

Options Traders Bet $550M Against Tesla Ahead of Earnings

Featured Reads

She's a 62-Year-Old Widow Banking on the COLA Raise. The Survivor-Benefit Timing She's Ignoring Is Worth Far More.

"Wait, Did I Just Hear That Right?": Suze Orman Catches a Caller's Advisor Overcharging Her by $23,000 a Year